2005
Guidant Announces Full Availability of Cardiac Rhythm Management Product Line Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Company Expects to Resume Implants and Distribution by Mid-week Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received U.S. Food and Drug Administration (FDA) approval to...
Robert J. Myerburg, M.D., Internationally Recognized Leader in Electrophysiology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Robert J. Myerburg, Professor of...
CE Mark Clears Way for Guidant to Reenter Market Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received Conformité Européenne (CE) Mark approval to launch its CONTAK...